Millions around the world are still waiting to get a life-saving vaccine—and it’s not the COVID-19 shot. Human trials of a new malaria vaccine are underway, with promising initial results, according to a new report by humanitarian agency GFA World that coincides with World Malaria Day, April 25, an annual event.
The quest to develop an effective malaria vaccine—a shot that could save millions of lives—has proved difficult and is still ongoing.
“Malaria is one of the most rampant child-killers in the world today,” said K.P. Yohannan, founder of Texas-based GFA World, formerly Gospel for Asia. “For countless millions across Africa, Asia and other parts of the world, an effective vaccine against malaria would be like a dream.”
COVID ‘Stalls Malaria Fight’
But with the world laser-focused on the global COVID-19 pandemic, efforts to wipe out malaria have stalled, the report says.
Lockdowns and other restrictions have essentially halted malaria-fighting efforts in dozens of countries, leading to fears of a sharp increase in malaria deaths in 2021—likely a death toll of hundreds of thousands in sub-Saharan Africa.
Malaria—an often-fatal sickness spread by infected mosquitoes—claims nearly half a million lives around the world every year, mostly in sub-Saharan Africa, and is “humanity’s most deadly infectious disease,” according to GFA World’s report.
Learn more how to save families and households from sickening agony or death from malaria through the gift of Mosquito Nets that offer protection from the sting of an infected mosquito and help to give their owner a restful nights sleep.
Learn more about Gospel for Asia: Facebook | YouTube | Instagram | LinkedIn | SourceWatch | Integrity | Lawsuit Update | 5 Distinctives | 6 Remarkable Facts | 10 Milestones | Media Room | Malaria & COVID-19 | Endorsements | 40th Anniversary | Lawsuit Response | International Offices | Missionary and Child Sponsorship | Transforming Communities through God’s Love